To study the Effectiveness of Individualized Homeopathic Treatment for Urinary Incontinence Using the ICIQ-UI Scale.

TO STUDY THE EFFICACY OF INDIVIDUALIZED HOMEOPATHIC MEDICINE IN URINARY INCONTINENCE BY USING ICIQ-UI SCALE:A SINGLE BLIND RANDOMIZED PLACEBO CONTROL TRAIL. - NIL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/097785

Enrollment

Registered

2025-11-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R32- Unspecified urinary incontinence

Interventions

Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINE: INDIVIDUALIZED HOMOEOPATHIC MEDICINE WILL BE PRESCRIBED IN SELECTIVE POTENCY AS IN REQUIRED REPETATION FOR 15 DAYS OR WHEN REQUIRED Control Interve

Eligibility

Inclusion criteria

Inclusion criteria: 1.Confirmed Diagnosis of one of the following type of urinary incontinence : stress,urge or mixed urinary incontinence 2. All Socioeconomic Status 3. No current treatment for urinary incontinence 4.patient having consent for the study.

Exclusion criteria

Exclusion criteria: 1. Patient using other medications or therapies for urinary incontinence. 2. Pregnancy,lactating or postpartum cases in women. 3. Patient with cognitive impairment. 4. Patient with bladder/pelvis abnormality like urethral diverticulum,vesicovaginal fistula or pelvic prolapse in female. 5. Patient suffering fromneurological disorders

Design outcomes

Primary

Measure	Time frame
1.Change in urinary incontinence severity measured using ICIQ-UI Score. Primary Outcome Description: Mean change in the ICIQ-UI total score (range 0 21; higher score = greater severity) from baseline to 12 weeks. The questionnaire will be self-administered by participants and scored as per ICIQ guidelines. Comparison will be made between individualized homeopathic medicine and placebo.Timepoint: 8Weeks to 12Weeks after randomization	—

Measure

Time frame

1.Change in urinary incontinence severity measured using ICIQ-UI Score. Primary Outcome Description: Mean change in the ICIQ-UI total score (range 0 21; higher score = greater severity) from baseline to 12 weeks. The questionnaire will be self-administered by participants and scored as per ICIQ guidelines. Comparison will be made between individualized homeopathic medicine and placebo.Timepoint: 8Weeks to 12Weeks after randomization

—

Secondary

Measure	Time frame
1.To study the efficacy of homeopathic individualized remedies and kegal exercise in cases of urinary incontinence by using ICIQ-UI Scale. 2.To assess the impact of Kegel exercise and placebo combination with kegel exerscise and homeopathic individualized remedies in urinary incontinence. Timepoint: 3 MONTHS	—

Countries

India

Contacts

Public ContactDR GAURAV SHARMA

JAWAHARLAL NEHRU HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

gaurav.sharma18479@paruluniversity.ac.in9824372731

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026